Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 7—July 2004
Research

Recombinant Viruses and Early Global HIV-1 Epidemic

Marcia L. Kalish*Comments to Author , Kenneth E. Robbins*, Danuta Pieniazek*, Amanda Schaefer*, Nzila Nzilambi†, Thomas C. Quinn†‡, Michael E. St. Louis*†, Ae S. Youngpairoj*, Jonathan Phillips*, Harold W. Jaffe*, and Thomas M. Folks*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Project SIDA, Kinshasa, Zaire; ‡National Institutes of Health, Bethesda, Maryland, USA

Main Article

Figure 3

Hypothetical model of HIV-1, group M evolution. A. Star phylogeny representing the evolution of the ancestral HIV-1, group M virus that was able to adapt in humans and was transmitted among rural populations in Central Africa from approximately the 1930s (22). Over time, the viruses would have become increasingly genetically distinct from each other and the original parental strain. The dotted circle denotes the beginning of migration from these remote areas to cities in Central Africa (approxim

Figure 3. Hypothetical model of HIV-1, group M evolution. A. Star phylogeny representing the evolution of the ancestral HIV-1, group M virus that was able to adapt in humans and was transmitted among rural populations in Central Africa from approximately the 1930s (22). Over time, the viruses would have become increasingly genetically distinct from each other and the original parental strain. The dotted circle denotes the beginning of migration from these remote areas to cities in Central Africa (approximately 1960–1970). B. Recombinant lineages outside the dotted circle, represented by multicolored lines indicating mosaic viruses or genetic mixes of the circulating strains, would have been the result of population migration, urbanization, patterns of sexual activity, and medical practices (two of the oldest, fully characterized sequences, MAL [1985] and Z321 [1976], were both recombinant viruses from Zaire). C. Recombinant viruses would have continued to be generated and transmitted until introduced into high-risk populations, such as commercial sex workers, taxi drivers, commercial truck drivers, or long-distance truck drivers, and then rapidly transmitted within and between these social networks. Such high-risk social networks throughout central Africa were responsible for the rapid expansion of a relatively small number of evolving viruses, including recombinant strains, locally, regionally, and eventually globally. These epidemiologic groupings are represented as clusters of highly related strains at the end of a few HIV-1 lineages. Panel C shows what phylogenetic analysis of global HIV-1 strains collected in the early 1990s, when sequence characterization first began, and after being exported out of central Africa, would have looked like. The clusters of related sequences from founder viruses, which were disseminated globally, would have appeared as subtypes or clades, arbitrarily labeled a-e. Occasionally strains that were not widely expanded were identified and designated as unclassifiable. From this hypothetical modeling, and the high numbers of recombinant strains, it seems unlikely that only pure subtypes were exported from this region of Africa to establish mini-epidemics in other countries. Therefore, at least some of what we currently define as pure subtypes most likely arose from recombinant genomes originally generated somewhere in central Africa.

Main Article

References
  1. Vidal  N, Peeters  M, Mulanga-Kabeya  C, Nzilambi  N, Robertson  D, Ilunga  W, Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol. 2000;74:10498–507. DOIPubMedGoogle Scholar
  2. Murphy  E, Korber  B, Georges-Courbot  MC, You  B, Pinter  A, Cook  D, Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. AIDS Res Hum Retroviruses. 1993;9:997–1006. DOIPubMedGoogle Scholar
  3. Yang  C, Dash  B, Hanna  SL, Frances  HS, Nzilambi  N, Colebunders  RC, Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo. AIDS Res Hum Retroviruses. 2001;17:361–5. DOIPubMedGoogle Scholar
  4. de Leys  R, Vanderborght  B, vanden Haesevelde M, Heyndrickx L, van Geel A, Wauters C, et al. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central Africa origin. J Virol. 1990;64:1207–16.PubMedGoogle Scholar
  5. Gurtler  LG, Hauser  PH, Eberle  J, von Brunn  A, Knapp  S, Zekeng  L, A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol. 1994;68:1581–5.PubMedGoogle Scholar
  6. Simon  F, Mauclere  P, Roques  P, Loussert-Ajaka  I, Muller-Trutwin  MC, Saragosti  S, Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med. 1998;4:1032–7. DOIPubMedGoogle Scholar
  7. Charneau  P, Borman  AM, Quillent  C, Guetard  D, Chamaret  S, Cohen  J, Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology. 1994;205:247–53. DOIPubMedGoogle Scholar
  8. Gao  F, Bailes  E, Robertson  DL, Chen  Y, Rodenburg  CM, Michael  SF, Origin of HIV-1 in chimpanzee Pan troglodytes troglodytes. Nature. 1999;397:436–41. DOIPubMedGoogle Scholar
  9. Hahn  GH, Shaw  GM, De Cock  KM, Sharp  PM. AIDS as a zoonosis: scientific and public health implications. Science. 2000;287:607–14. DOIPubMedGoogle Scholar
  10. Mann  JM, Francis  H, Quinn  T, Asila  PK, Bosenge  N, Nzilambi  N, Surveillance for AIDS in a central African city, Kinshasa, Zaire. JAMA. 1986;255:3255–9. DOIPubMedGoogle Scholar
  11. Nzilambi  N, De Cock  KM, Forthal  DN, Francis  H, Ryder  RW, Malbe  I, The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N Engl J Med. 1988;318:276–9. DOIPubMedGoogle Scholar
  12. Mulanga-Kabeya  C, Nzilambi  N, Edidi  B, Minlangu  M, Tshimpaka  T, Kambembo  L, Evidence of stable HIV seroprevalences in selected populations in the Democratic Republic of the Congo. AIDS. 1998;12:905–10. DOIPubMedGoogle Scholar
  13. Mann  JM, Nzilambi  N, Piot  P, Bosenge  N, Kalala  M, Francis  H, HIV infection and associated risk factors in female prostitutes in Kinshasa, Zaire. AIDS. 1988;2:249–54. DOIPubMedGoogle Scholar
  14. N’Galy  B, Ryder  RW, Bila  K, Mwandagalirwa  G, Colebunders  RL, Francis  H, Human immunodeficiency virus infection among employees in an African hospital. N Engl J Med. 1988;319:1123–7. DOIPubMedGoogle Scholar
  15. Ellenberger  DL, Pieniazek  D, Nkengasong  J, Luo  C-C, Maurice  C, Janini  M, Genetic analysis of human immunodeficiency virus in Abidjan, Cote d’Ivoire reveals predominance of HIV-1 subtype A and introduction of subtype G. AIDS Res Hum Retroviruses. 1999;15:3–9. DOIPubMedGoogle Scholar
  16. Schochetman  GS, Subbarao  S, Kalish  ML. Methods for studying genetic variation of the human immunodeficiency virus (HIV). In: Adolph KA, editor. Viral genome methods. Boca Raton (FL): CRC Press; 1996. p. 25–41.
  17. Yang  C, Pieniazek  D, Owen  SM, Fridlund  C, Nkengasong  J, Mastro  TD, Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol. 1999;37:2581–6.PubMedGoogle Scholar
  18. Posada  D, Crandall  KA. MODELTEST: testing the model of DNA substitution. Bioinformatics. 1998;14:817–8. DOIPubMedGoogle Scholar
  19. Swofford  DL. PAUP* Phylogenetic Analysis Using Parsimony (*and Other Methods) Version 4. Sunderland (MA): Sinauer Associates; 2003.
  20. Iglesias-Sanchez  MJ, Lopez-Galindez  C. Analysis, quantification, and evolutionary consequences of HIV-1 in vitro recombination. Virology. 2002;304:392–402. DOIPubMedGoogle Scholar
  21. Anderson  JP, Rodrigo  AG, Learn  GH, Madan  A, Delahunty  C, Coon  M, Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. J Virol. 2000;74:10752–65. DOIPubMedGoogle Scholar
  22. Oucho  JO, Gould  WTS. Chapter 7: internal migration, urbanization, and population distribution. In: Foote KA, Hill KH, Martin LG, editors. Demographic change in sub-Saharan Africa. Washington (DC): National Academy Press; 1993. p. 256–96.
  23. Quinn  TC. The global burden of the HIV pandemic. Lancet. 1996;348:99–106. DOIPubMedGoogle Scholar
  24. Mann  JM, Francis  H, Davachi  F, Baudoux  P, Quinn  TC, Nzilambi  N, Risk factors for human immunodeficiency virus seropositivity among children 1 to 24 months old in Kinshasa, Zaire. Lancet. 1986;2:654–7. DOIPubMedGoogle Scholar
  25. Mann  JM, Francis  H, Davachi  F, Baudoux  P, Quinn  TC, Nzilambi  N, Human immunodeficiency virus seroprevalence in pediatric patients 2 to 14 years of age at Mama Yemo Hospital, Kinshasa, Zaire. Pediatrics. 1986;78:673–7.PubMedGoogle Scholar
  26. Mann  JM, Francis  H, Quinn  TC, Bila  K, Asila  PK, Bosenge  N, HIV seroprevalence among hospital workers in Kinshasa, Zaire. JAMA. 1986;256:3099–102. DOIPubMedGoogle Scholar
  27. Greenberg  AE, Nguyen-Dinh  P, Mann  JM, Kobote  N, Colebunders  RL, Francis  H, The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. JAMA. 1988;259:545–9. DOIPubMedGoogle Scholar
  28. Jager  H, N’Galy  B, Perriens  J, Nseka  K, Davachi  F, Kabeya  CM, Prevention of transfusion-associated HIV transmission in Kinshasa, Zaire: HIV screening is not enough. AIDS. 1990;4:571–4. DOIPubMedGoogle Scholar
  29. N’tita  I, Mulanga  K, Dulat  C, Lusamba  D, Rehle  T, Korte  R, Risk of transfusion-associated HIV transmission in Kinshasa, Zaire. AIDS. 1991;5:437–9. DOIPubMedGoogle Scholar
  30. Gaschen  B, Taylor  J, Yusim  K, Foley  B, Gao  F, Lang  D, Diversity considerations in HIV-1 vaccine selection. Science. 2002;296:2354–60. DOIPubMedGoogle Scholar
  31. Nickle  DC, Jensen  MA, Gottlieb  GS, Shriner  D, Learn  GH, Rodrigo  AG, Consensus and ancestral state HIV vaccines. Science. 2003;299:1515–8. DOIPubMedGoogle Scholar
  32. Ramos  A, Hu  DJ, Nguyen  L, Phan  KO, Vanichseni  S, Promadej  N, Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol. 2002;76:7444–52. DOIPubMedGoogle Scholar
  33. Schierup  MH, Hein  J. Consequences of recombination on traditional phylogenetic analysis. Genetics. 2000;156:879–91.PubMedGoogle Scholar
  34. Wain-Hobson  S, Renoux-Elbe  C, Vartanian  J-P, Meyerhans  A. Network analysis of human and simian immunodeficiency virus sequence sets reveals massive recombination resulting in shorter pathways. J Gen Virol. 2003;84:885–95. DOIPubMedGoogle Scholar
  35. Korber  B, Muldoon  M, Theiler  J, Gao  F, Gupta  R, Lapedes  A, Timing the ancestor of the HIV-1 pandemic strains. Science. 2000;288:1789–96. DOIPubMedGoogle Scholar

Main Article

Page created: January 27, 2011
Page updated: January 27, 2011
Page reviewed: January 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external